Search Results - "Bömmel, F."

Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry by Welzel, T. M., Hinrichsen, H., Sarrazin, C., Buggisch, P., Baumgarten, A., Christensen, S., Berg, T., Mauss, S., Teuber, G., Stein, K., Deterding, K., Bömmel, F., Heyne, R., John, C., Zimmermann, T., Lutz, T., Schott, E., Hettinger, J., Kleine, H., König, B., Hüppe, D., Wedemeyer, H.

“…Summary Real‐world studies are relevant to complement clinical trials on novel antiviral therapies against chronic hepatitis C; however, clinical practice data…”
Get full text

Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV type by Fülöp, B., Mihm, U., Rohde, P., Buggisch, P., Schlosser, B., Biermer, M., Brodzinski, A., Fischer, J., Böhm, S., van Bömmel, F., Sarrazin, C., Berg, T.

“…Summary The mode of action of ribavirin is not completely understood. Ribavirin monotherapy has a measurable antiviral effect, which shows great variability…”
Get full text

Toll-like receptor 5 polymorphism at position c. 1846T > C is associated with the development of hepatocellular carcinoma in caucasians with chronic hepatitis B infection by Koukoulioti, E, Fischer, J, Schott, E, Fueloep, B, Heyne, R, Berg, T, van Bömmel, F

Get full text

Common polymorphisms in the TLR3 gene are stronger associated with spontaneous clearance of Hepatitis B virus infection in caucasians than variants of the HLA gene by Fischer, J, Koukoulioti, E, Schott, E, Fueloup, B, Heyne, R, Berg, T, van Bömmel, F

Get full text

HBsAg loss during treatment with nucleo(s)tide analogues is preceded by changes of the composition of the hepatitis B virus surface antigen (HBsAg) by Grossmann, M, Schott, T, Felkel, C, Boehm, S, Glebe, D, Berg, T, Van Bömmel, F

Get full text

Evaluation of serum HBV RNA and HBcrAg in chronic hepatitis B patients achieving different serological outcomes on tenofovir disoproxil fumarate (TDF) by Cathcart, A.L, Buti, M, Marcellin, P, Gaggar, A, Delaney, W, Kitrinos, K.M, van Bömmel, F

Get full text

High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy by Biermer, M., Schlosser, B., Fülöp, B., van Bömmel, F., Brodzinski, A., Heyne, R., Keller, K., Sarrazin, C., Berg, T.

“…Incomplete suppression of hepatitis C virus (HCV) replication with persistence of minimal viremia (partial virologic response) leading to treatment failure can…”
Get full text

P0561 : Differences in quantitative composition of large, middle and small hepatitis B virus (HBV) surface antigen (HBsAg) In acute and chronic HBV infection by Grossmann, M, Böhm, S, Glebe, D, Berg, T, van Bömmel, F

Get full text

The Human Leukocyte Antigen -DPA1 RS3077 TT Polymorphism is Associated with Spontaneous Clearance of HBS Antigen in Caucasians with Chronic Hepatitis B by Koukoulioti, E, Fischer, J, Böhm, S, Schott, E, Fülöp, B, Heyne, R, Berg, T, van Bömmel, F

Get full text

Association of a Common Polymorphism in the Toll-Like Receptor (TLR) 3 Gene with Spontaneous HBS Antigen Clearance by Fischer, J, Koukoulioti, E, Böhm, S, Schott, E, Fülöp, B, Heyne, R, Berg, T, van Bömmel, F

Get full text

Serum hepatitis B virus RNA level is associated with hepatitis B virus genotype and BCP mutations in untreated patients with HBeAg positive chronic hepatitis B by van Campenhout, M.J, van Bömmel, F, Grossmann, M, Fischer, J, Deichsel, D, Boonstra, A, van Vuuren, A.J, Berg, T, Hansen, B.E, Janssen, H.L

Get full text

Serum HBV RNA level monitoring for response prediction in HBeAg positive chronic hepatitis B infection by van Campenhout, M.J, van Bömmel, F, Grossmann, M, Fischer, J.J, Deichsel, D, Boonstra, A, van Vuuren, A.J, Berg, T, Hansen, B.E, Janssen, H.L

Get full text

Immune checkpoint inhibition (ICI) in current systemic therapies for hepatocellular carcinoma (HCC) by F. van Bömmel, T. Berg, F. Lordick

“…Immune checkpoint inhibition (ICI) has revolutionized cancer therapy, including treatment of hepatocellular carcinoma (HCC) which comprises 80%-90% of all…”
Get full text

P0643 : Serum HBV RNA is an early predictor of HBeAg seroconversion in patients with chronic hepatitis B (CHB) treated with Peg-Interferon alpha-2A (40kD) by van Bömmel, F, van Bömmel, A, Krauel, A, He, H, Wat, C, Pavlovic, V, Deichsel, D, Berg, T, Böhm, S

Get full text

Impact of Dynamic Viral and Biochemical Parameters on Progression of Liver Fibrosis in a Cohort of Inactive European Hepatitis B (HBV) Carriers: A Prospective Longitudinal Study (Albatros Study) by Knop, V, Vermehren, J, Petersen, J, Buggisch, P, Wedemeyer, H, Cornberg, M, Mauss, S, Sprinzl, M, Berg, T, van Bömmel, F, Klinker, H, Hüppe, D, Bronowicki, J.-P, Rausch, M, Welzel, T, Vermehren, A, Susser, S, Zeuzem, S, Sarrazin, C

Get full text

P1095 HBVRNA IN SERUM IS A PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING TREATMENT WITH PEG-INTERFERON ALPHA-2a (40KD) by van Bömmel, F, van Bömmel, A, He, H, Wat, C, Deichsel, D, Berg, T, Böhm, S

Get full text

P0661 : Prediction of HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients treated with entecavir using ALT and platelet count: Results from a large european multi-center study by Chi, H, van Bömmel, F, Buti, M, Brown, A, Carey, I, Fasano, M, Mutimer, D, Deterding, K, Oo, Y, Arends, P, de Knegt, R.J, Santantonio, T, Welzel, T.M, Pradat, P, Petersen, J, Wedemeyer, H, Berg, T, Zoulim, F, Hansen, B.E, Janssen, H.L

Get full text

P0581 : Prediction of HBsAg seroclearance and HBsAg seroconversion in a cohort of inactive european hepatitis B (HBV) carriers: A prospective longitudinal study (albatros study) by Knop, V, Herrmann, E, Vermehren, J, Petersen, J, Buggisch, P, Wedemeyer, H, Cornberg, M, Mauss, S, Sprinzl, M, Berg, T, van Bömmel, F, Klinker, H, Hüppe, D, Rausch, M, Welzel, T, Vermehren, A, Susser, S, Zeuzem, S, Sarrazin, C

Get full text

Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation by R. Veelken, S. Ebel, A. Schindler, F. Lordick, M.F. Struck, C. Girbardt, F. Ziemssen, D. Seehofer, T. Denecke, T. Berg, F. van Bömmel

“…Background: Hepatic chemosaturation by isolated percutaneous liver perfusion (CS-PHP) with melphalan controls hepatic tumor growth. However, optimal treatment…”
Get full text

Genotype-Specific Synthesis and Secretion of Spliced Hepatitis B Virus Genomes in Hepatoma Cells by Sommer, G., van Bömmel, F., Will, H.

“…Hepatitis B virus-infected patients frequently have viral particles with DNA derived from differently spliced RNA. Which factors influence the synthesis of…”
Get full text